pharma
GSK gets FDA approval for key triple therapy inhaler
September 20, 2017Research and Development, Sales and Marketing GSK, Trelegy Ellipta, biotech, drugs, pharma, pharmaceutical
The good news keeps on rolling in for GSK, with the FDA approval for its triple therapy inhaler.
Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint
September 19, 2017Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical
Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …
Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab
September 19, 2017Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
FDA locks down combo immunotherapy trials, Roche added to hold
September 19, 2017Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq
The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
Teva completes sale of women’s health for $1.38 billion
September 19, 2017Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
Swine flu pandemic linked to increased incidence of diabetes
September 19, 2017Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu
The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …
Scholar Rock prise Regulatory Affairs director away from Biogen
September 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical
Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Novartis’ Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria
September 18, 2017Research and Development, Sales and Marketing Novartis, Xolair, chronic spontaneous urticarial, pharma, pharmaceutical
Novartis has released new data demonstrating the efficacy of Xolair (omalizumab) in the treatment of chronic spontaneous urticaria (CSU), a …
Standing together: Supercharging the clinical trial in Europe
September 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical
The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
FDA approves first medical app, for use in addiction
September 18, 2017Sales and Marketing Pear Therapeutics, biotech, drugs, pharma, pharmaceutical, reset
The FDA has taken a major step in the digitisation of healthcare by handing out the first medical app approval: …
China’s Fosun Group grabs 74% stake in India’s Gland Pharma for $1.1 billion
September 18, 2017Sales and Marketing China, Fosun Pharma, Gland Pharma, India, pharma, pharmaceuticals
Chinese conglomerate Fosun has agreed to acquire 74% of India’s Gland Pharma for $1.1 billion, sealing a previously unsuccessful deal …
Bayer lymphoma treatment speeds to FDA approval
September 18, 2017Sales and Marketing Aliqopa, Bayer, biotech, drugs, pharma, pharmaceutical
The FDA gave Bayer priority review for its treatment Aliqopa (copanlisib) in May of this year, and it quickly came …
Santhera ‘surprised’ by European rejection of DMD drug
September 18, 2017Sales and Marketing Duchenne Muscular Dystrophy, biotech, drugs, pharma, pharmaceutical, santhera
Santhera Pharmaceutical has announced the EMA’s CHMP rejected its treatment for Duchenne muscular dystrophy (DMD) but revealed that it planned …
Top Ten most popular articles on Pharmafile.com this week
September 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten
This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
Pfizer receives prostate cancer drug boost with trial results
September 15, 2017Medical Communications, Research and Development Astellas, Pfizer, Xtandi, biotech, drugs, pharma, pharmaceutical
Pfizer, and its partner Astellas Pharma, received a major boost to its plans for prostate cancer treatment, Xtandi, by announcing …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
